Anticholinergic drugs tied to increased r... - Cure Parkinson's

Cure Parkinson's

26,583 members27,899 posts

Anticholinergic drugs tied to increased risk of cognitive decline - Alzheimer's - Parkinson's, etc.

aspergerian profile image
6 Replies

Anticholinergic drugs tied to increased risk of cognitive decline - Alzheimer's - Parkinson's, etc.

medicalxpress.com/news/2020...

Written by
aspergerian profile image
aspergerian
To view profiles and participate in discussions please or .
Read more about...
6 Replies
pvw2 profile image
pvw2

Use of anticholinergic drugs does not increase risk for dementia in Parkinson's disease patients

medicalxpress.com/news/2016...

List of Anticholinergics/antispasmodics:

drugs.com/drug-class/antich...

aspergerian profile image
aspergerian in reply topvw2

See:

Patients with Parkinson’s disease have an elevated risk of dementia;44 anticholinergic antiparkinson drugs have previously been associated with greater cognitive decline.45 This study provides further evidence that anticholinergic drugs should be avoided when treating patients with Parkinson’s disease.

In each case (antidepressants, antiparkinsons, and urologicals with an ACB score of 3) a dose-response effect is seen with a smaller, but noticeable, positive association between dementia and recorded use of less than 90 DDDs (see supplementary materials, table 2). It is possible that in some cases these low exposures reflect a longer exposure that is not captured in the patients’ current primary care record.

bmj.com/content/361/bmj.k1315

Patients with Parkinson’s disease have an elevated risk of dementia;44 anticholinergic antiparkinson drugs have previously been associated with greater cognitive decline.45 This study provides further evidence that anticholinergic drugs should be avoided when treating patients with Parkinson’s disease.

In each case (antidepressants, antiparkinsons, and urologicals with an ACB score of 3) a dose-response effect is seen with a smaller, but noticeable, positive association between dementia and recorded use of less than 90 DDDs (see supplementary materials, table 2). It is possible that in some cases these low exposures reflect a longer exposure that is not captured in the patients’ current primary care record.

bmj.com/content/361/bmj.k1315

bmj.com/content/361/bmj.k1315

MBAnderson profile image
MBAnderson in reply topvw2

The article was somewhat distressing because I take 1 of those drugs on the list, but then I, too, noticed the link below the article that you posted which offered us another article indicating just the opposite. "Use of anticholinergic drugs does not increase risk for dementia in Parkinson's disease patients."

Once again, for every study we find that says one thing, we can find another study that says the opposite.

ElliotGreen profile image
ElliotGreen in reply toMBAnderson

There are quite a number of studies linking anticholinergic use to short-term cognitive impairment and longer-term increased risks of dementia.

pvw2 profile image
pvw2

"Note that medications that relax the urethra, such as tamsulosin or terazosin (Flomax and Hytrin, respectively) are NOT anticholinergic. So they’re not risky in the same way, although they can cause orthostatic hypotension and other problems in older adults." {My understanding is that they tend to lower blood pressure.}

4 Types of Brain-Slowing Medication to Avoid if You’re Worried About Memory

betterhealthwhileaging.net/....

MarionP profile image
MarionP

That is a small list of anticholinergics, aren't there more?

Not what you're looking for?

You may also like...

Flavonoids Not Tied to Reduced Parkinson's Risk 2024

Flavonoids Not Tied to Reduced Parkinson's Risk 2024...
Bolt_Upright profile image

Risk From Pesticides Use linked to Parkinson's

We already knew that, didn't we?...
pdpatient profile image

Could prostate drugs reduce Parkinson's disease risk?

https://www.medicalnewstoday.com/amp/articles/could-prostate-drugs-reduce-parkinsons-disease-risk A...
JayPwP profile image

long-term Lithium use tied to higher risk of VTE, Parkinson and kidney diseases

https://medicaldialogues.in/psychiatry/news/long-term-lithium-use-tied-to-higher-risk-of-vte-parkins
Farooqji profile image

Higher doses of omega-3 supplements may be needed for averting cognitive decline

https://www.news-medical.net/amp/news/20200719/Higher-doses-of-omega-3-supplements-may-be-needed-for
JayPwP profile image